NEW YORK, Dec. 30, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTK, NEW, DIDI, IQ, and BBIO.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • CTK: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=CTK&prnumber=123020215 
  • NEW: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=NEW&prnumber=123020215 
  • DIDI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=DIDI&prnumber=123020215 
  • IQ: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=IQ&prnumber=123020215 
  • BBIO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=BBIO&prnumber=123020215 

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-cootek-puxin-didi-global-iqiyi-or-bridgebio-pharma-301451921.html

SOURCE InvestorsObserver